Effect of dexamethasone on fetal hepatic glutamine-glutamate exchange

Abstract

Intravenous infusion of dexamethasone (Dex) in the fetal lamb causes a two- to threefold increase in plasma glutamine and other glucogenic amino acids and a decrease of plasma glutamate to approximately one-third of normal. To explore the underlying mechanisms, hepatic amino acid uptake and conversion ofl-[1-13C]glutamine tol-[1-13C]glutamate and13CO2 were measured in six sheep fetuses before and in the last 2 h of a 26-h Dex infusion. Dex decreased hepatic glutamine and alanine uptakes ( P < 0.01) and hepatic glutamate output ( P < 0.001). Hepatic outputs of the glutamate (RGlu,Gln) and CO2 formed from plasma glutamine decreased to 21 ( P < 0.001) and 53% ( P= 0.009) of control, respectively. RGlu,Gln, expressed as a fraction of both outputs, decreased ( P < 0.001) from 0.36 ± 0.02 to 0.18 ± 0.04. Hepatic glucose output remained virtually zero throughout the experiment. We conclude that Dex decreases fetal hepatic glutamate output by increasing the routing of glutamate carbon into the citric acid cycle and by decreasing the hepatic uptake of glucogenic amino acids.